REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/09/2026
Back to search
Official data from USPTO
EXUBRION THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EXUBRION THERAPEUTICS
ST13
US500000088418293Class
5
Filing
88418293
Registration
6290107
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
03/10/2026
Trademark type
Word
Nice classes
5
Filing date
05/07/2019
Registration date
03/09/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/09/2021
Last transaction
03/10/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/06/2020
First use in commerce
08/06/2020
Drawing code
4
Owner type
03
Owner location
Buford, GA, US
Examiner
HSU, FONG
Law office
O20
Current location
TMO LAW OFFICE 129 - EXAMINING ATTORNEY ASSIGNED
Holders and representatives
Holders
Convetra Inc.
Representatives
Kurt A. Summe Wood Herron & Evans, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Veterinary preparationsveterinary radio-therapeutic preparations
Publications
History of USPTO decisions and trademark events.
27 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/09/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/04/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/03/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/13/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/11/2021
IUAF
USE AMENDMENT FILED
12/22/2020
EISU
TEAS STATEMENT OF USE RECEIVED
12/22/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/25/2020
EX1G
SOU EXTENSION 1 GRANTED
06/23/2020
EXT1
SOU EXTENSION 1 FILED
06/23/2020
EEXT
SOU TEAS EXTENSION RECEIVED
06/23/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/24/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/29/2019
PUBO
PUBLISHED FOR OPPOSITION
10/29/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/09/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/19/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/18/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/18/2019
ALIE
ASSIGNED TO LIE
09/17/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/11/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/29/2019
GNRT
NON-FINAL ACTION E-MAILED
07/29/2019
CNRT
NON-FINAL ACTION WRITTEN
07/29/2019
DOCK
ASSIGNED TO EXAMINER
07/22/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/22/2019
NWAP
NEW APPLICATION ENTERED
05/10/2019
Continuous trademark protection
Get notified about every new filing that threatens EXUBRION THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.